BioSpace News Archive

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Canaccord Genuity 40th Annual Growth Conference, to be held virtually on Wednesday, August 13, 2020.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as an independent member of its board of directors effective August 3, 2020.

Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced the submission of their Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for idecabtagene vicleucel (ide-cel; bb2121), the companies’ investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy, for the treatment of adult patients with relapsed and refractory multiple myeloma.

Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced it will participate in the LifeSci Partners Private Company Virtual Summer Symposium, taking place August 4-5, 2020. The company will deliver a corporate update to potential investors and strategic partners, among other various relevant audiences. The corporate update will cover recent and upcoming Company milestones, as well as detail clinical progress of the Company

FBSciences Inc., a global leader in naturally derived plant health technologies and products, is accelerating its collaboration agreement with Yara North America by expanding its line of calcium nitrate (CN) compatible products.

#MyCleanAirStory social media campaign to amplify voices, elevate conversations and personal stories on the health impacts of climate change, air pollution

McDermott Will & Emery, the nation’s leading health law firm, announces Brian Malkin has joined as partner in the FDA practice of its Health Industry Advisory group based in Washington, DC.

As healthcare organizations across the country are overwhelmed with patient intake processes, many have turned to eHealth Technologies to effectively streamline patient care

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal second quarter 2020 financial results on Wednesday, August 5, 2020 at 8:00 AM ET. Management will host a conference call at 8:30AM ET, to review financial results and provide an update on corporate developments. Following management’s fo

Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today the company will be participating in the upcoming virtual Canaccord 40th Annual Growth Conference.